
CureVac N.V. — Investor Relations & Filings
CureVac N.V. is a global biopharmaceutical company that develops transformative medicines based on messenger ribonucleic acid (mRNA). With over two decades of experience, the company leverages its proprietary mRNA technology platform to enable the human body to produce its own therapeutic proteins to fight a wide range of diseases. CureVac's clinical development pipeline is focused on creating prophylactic vaccines for infectious diseases, as well as therapies in oncology and for rare diseases. The company collaborates with partners to advance its portfolio of mRNA-based candidates.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 15-12G | 2026-01-16 | English | |
| S-8 POS | 2026-01-07 | English | |
| Delisting Announcement 2026 | 2026-01-06 | English | |
| 6-K | 2026-01-06 | English | |
| SC 14D9/A | 2025-12-18 | English | |
| Major Shareholding Notification 2025 | 2025-12-12 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
4 filings
| |||||
| 13250193 | 15-12G | 2026-01-16 | English | ||
| 13250194 | S-8 POS | 2026-01-07 | English | ||
| 13250195 | Delisting Announcement 2026 | 2026-01-06 | English | ||
| 13250196 | 6-K | 2026-01-06 | English | ||
|
2025
11 filings
| |||||
| 13250197 | SC 14D9/A | 2025-12-18 | English | ||
| 13250198 | Major Shareholding Notification 2025 | 2025-12-12 | English | ||
| 13250199 | Major Shareholding Notification 2025 | 2025-12-12 | English | ||
| 13250200 | Major Shareholding Notification 2025 | 2025-12-12 | English | ||
| 13250201 | SC 14D9/A | 2025-12-05 | English | ||
| 13250202 | SC 14D9/A | 2025-11-26 | English | ||
| 13250203 | FORM 6-K | 2025-11-26 | English | ||
| 13250204 | SC 14D9/A | 2025-11-25 | English | ||
| 13250205 | SC 14D9/A | 2025-11-24 | English | ||
| 13250206 | FORM 6-K | 2025-11-24 | English | ||
| 13250207 | FORM 6-K | 2025-10-27 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Bicara Therapeutics Inc.
Clinical-stage biopharma developing dual-action biologics f…
|
BCAX | US | Manufacturing |
|
BICYCLE THERAPEUTICS PLC
Clinical-stage biopharma developing a novel class of bicycl…
|
BCYC | GB | Manufacturing |
|
BIFIDO. Co. Ltd
Biotechnology firm developing human-derived Bifidobacterium…
|
238200 | KR | Manufacturing |
|
Binex Co., Ltd.
Biopharmaceutical firm with pharma manufacturing and biolog…
|
053030 | KR | Manufacturing |
|
BioAge Labs, Inc.
A clinical-stage biotech developing therapies for metabolic…
|
BIOA | US | Manufacturing |
|
Bioasis Technologies Inc.
Developing the xB3 platform to deliver therapeutics across …
|
BIOAF | CA | Manufacturing |
|
BioAtla, Inc.
Develops antibody-based therapeutics activated within the t…
|
BCAB | US | Manufacturing |
|
BIOBIJOU Co., Ltd.
Develops and manufactures medical aesthetic products like H…
|
489460 | KR | Manufacturing |
|
BioCardia, Inc.
Develops cell-derived therapeutics for cardiovascular and p…
|
BCDA | US | Manufacturing |
|
Biocartis Group NV
Develops and commercializes an automated molecular diagnost…
|
BCART | BE | Manufacturing |
CureVac N.V. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32086/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32086 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32086 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32086 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32086}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CureVac N.V. (id: 32086)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.